Summary | Fosun partners with Kite Pharm to bring T-cell
therapy to China - Business - Chinadaily.Different from
chemotherapy and radiotherapy, T-cell therapy is based on
genetical engineering.Each of the two parties owns 50 percent
equity interests in the cooperative enterprise.The enterprise
eyes to bring cutting-edge treatments to patients in need, said ...
therapy to China - Business - Chinadaily.Different from
chemotherapy and radiotherapy, T-cell therapy is based on
genetical engineering.Each of the two parties owns 50 percent
equity interests in the cooperative enterprise.The enterprise
eyes to bring cutting-edge treatments to patients in need, said ...
chinadaily.com.cn | 02 August 2017